The Winklevoss twins explain why bringing regulation to the crypto market isn't a zero-sum game

Dan DeFrancesco | The cofounders of the Gemini cryptocurrency exchange talk about why their pro-regulation approach can coexist with crypto extremism.

Read More »

Balyasny loses a quant portfolio manager as the manager gets its footing after a disappointing 2018

Bradley Saacks | Paul Chambers joined Balyasny's London office at the end of 2017, after roughly a decade at Man Group. He is now returning to Man Group less than two years later, sources say.

Read More »

Even the world's top firms pay Rob Arnott for advice. He explains why a $1 trillion investing industry is built on a flawed premise — and why that's hurting retirement savings.

Joe Ciolli | The smart-beta pioneer Rob Arnott says target-date funds adhere to flawed investing conventions, making them a poor option for retirement savings.

Read More »

The world's largest hedge fund just warned that the 'most pro-corporate environment in history' is in danger — and said the fallout could send stocks plunging

Akin Oyedele | Bridgewater warns it will be tough for companies to maintain current levels of profits and increase margins from here.

Read More »

Founders Fund made its first alcohol investment. Here’s how the 28-year old woman who founded the company is trying to change drinking culture for the better.

Megan Hernbroth | Founders Fund backs female-led Bev in the fund's first alcohol investment. Here’s how its founder is trying to change drinking culture for the better.

Read More »

Pinterest's IPO team wants to convince investors that it has more in common with Google than Snap

Becky Peterson | Pinterest is expected to price its IPO on Wednesday night.

Read More »

Google's Waze wants more outdoor advertising dollars. Here are pitch decks it is using to sell itself as a complement to out-of-home ads.

Tanya Dua | We compiled slides from recent pitch decks to agencies that Waze is using to pitch itself as a "digital out-of-home" platform.

Read More »

'Vulnerable to catastrophe': One market bear explains why stocks will crash 30% by the end of 2019 — and then flatline for the next 12 years

Joe Ciolli | The renowned market bear John Hussman lays out why he thinks the S&P 500 is in for a tough, money-losing road ahead.

Read More »

A Jeff Bezos-backed startup just inked a deal with $84 billion biotech Gilead to make drugs for a troubling and increasingly common disease

Erin Brodwin | Insitro and Gilead are teaming up to create drugs for a liver disease affecting millions. The startup is backed by Jeff Bezos and Andreessen Horowitz.

Read More »